To provide for a limitation on the transfer of defense articles and defense services to Israel.

1) What happened: On May 21, 2025, Rep. Ramirez (D-IL) introduced HR3565, which prohibits the President from transferring nine specific defense articles and related services to Israel unless (a) a law specifies the exact purpose of use, and (b) Israel provides written assurances of compliance with international humanitarian law. The bill was referred to the House Foreign Affairs Committee and has 68 cosponsors, all Democrats. It has not advanced beyond referral and has no companion Senate bill. 2) The money trail: This bill does not authorize or appropriate any funds. It creates a RESTRICTION on existing arms transfer authorities under the Arms Export Control Act and Foreign Assistance Act. The financial impact is measured in lost export revenue for U.S. manufacturers — Israel is typically among the top three global recipients of U.S. defense articles by dollar value. The covered articles include high-volume items: JDAM kits, SPICE assemblies, 155mm ammunition, MK80 bombs, and bunker busters. Industry estimates place annual Israeli procurement of these items in the $800M-$1.5B range. 3) Structural winners and losers: There are NO winners from this bill in the publicly traded defense sector — it is purely a revenue restriction. The most exposed tickers are $LMT (JDAM kits, BLU-109), $RTX (SPICE, SDB), and $BA (JDAM, MK80), followed by $NOC and $GD (155mm artillery). Smaller munition suppliers like $KTOS (Kratos), $AERO (AeroVironment), and $TDG (TransDigm) have minimal direct Israeli exposure on these specific articles. 4) Market data analysis: Real price action over the 7 days ending April 30, 2026 shows mixed performance — LMT fell 0.96%, RTX rose 0.13%, BA fell 2.39%, NOC rose 0.09%, GD rose 9.01%. Over 30 days, LMT is down 15.87%, NOC down 15.62%, RTX down 9.55%, and BA up 13.99%. GD's 9.01% 7-day surge appears to be a separate catalyst (strong earnings or contract win). The 30-day declines in LMT, NOC, and RTX are severe and likely reflect broader defense budget uncertainty and the post-peak defense cycle, not this single early-stage bill. HR3565 adds incremental negative sentiment but is not the primary driver of those moves. 5) Timeline: HR3565 has zero legislative velocity — introduced, referred, no committee markups, no hearings, no Senate companion. For it to reach enactment, it must clear House Foreign Affairs (likely not under Republican leadership), pass the full House, pass the Senate, and survive a presidential veto. The current House leadership and committee chairs are opposed to such restrictions. Realistic probability of enactment in the 119th Congress: <5%. The bill's primary market impact is as a POLITICAL SIGNAL — it demonstrates growing congressional willingness to condition arms sales to Israel, which could influence future executive branch decisions on individual notifications.